Where Are We Now in the Use of Interleukin-17 Inhibitors for Psoriatic Disease?

Can you navigate the increasingly complex treatment landscape for psoriasis and psoriatic arthritis (PsA)? Earn Credit / Learning Objectives & Disclosures:  https://www.medscape.org/viewarticle/985565?ecd=bdc_podcast_libsyn_mscpedu